Are OA and Statins Connected?

APRIL 01, 2005

Older women taking statins may have an increased risk of developing osteoarthritis (OA). The researchers reported, however, that patients who already have the degenerative joint disease do not seem to be negatively affected by these drugs. In theory, the researchers noted that statins can lower the risk of OA because of their anti-inflammatory effects. Yet, their actual impact on OA is unknown.

The study included 5674 women 65 years and older. Of the participants, 7% took statins. At the study's onset, OA—detected by x-ray—was present in 936 hips in 745 women, while 9318 hips had no indications of OA. After 8 years of follow-up, the researchers found that statin use was linked with a 92% increased risk of OA of the hip. Yet, the use of statins was not related to other measures of new disease. The researchers also witnessed a consistent trend toward slower progression in the statin group who had OA of the hip at the beginning of the study. (The findings were reported in the Journal of Rheumatology, January 2005.)


Become a Respimat Top Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc. 

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today? 


Pharmacy Times Strategic Alliance

Pharmacist Education
Clinical features with downloadable PDFs

Next-Generation Pharmacist® Awards

3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference

Personalize the information you receive by selecting targeted content and special offers.